| Market Cap | 25.67B | P/E | 49.44 | EPS this Y | 29.00% | Ern Qtrly Grth | 12.00% |
| Income | 287.88M | Forward P/E | - | EPS next Y | 12.50% | 50D Avg Chg | 2.00% |
| Sales | 2.54B | PEG | - | EPS past 5Y | - | 200D Avg Chg | 16.00% |
| Dividend | 5.00% | Price/Book | 13.62 | EPS next 5Y | - | 52W High Chg | -7.00% |
| Recommedations | 1.00 | Quick Ratio | 1.29 | Shares Outstanding | 1.59B | 52W Low Chg | 83.00% |
| Insider Own | - | ROA | 10.91% | Shares Float | 107.22M | Beta | 1.22 |
| Inst Own | 0.00% | ROE | 14.98% | Shares Shorted/Prior | -/- | Price | 15.82 |
| Gross Margin | 72.69% | Profit Margin | 10.65% | Avg. Volume | 40,256 | Target Price | 16.00 |
| Oper. Margin | 26.56% | Earnings Date | Aug 14 | Volume | 96,799 | Change | -3.12% |
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
| BNP Paribas | Outperform | Jul 8, 21 |